摘要
目的:探讨口服红色诺卡氏菌细胞壁骨架制剂nocardiarubracellwal(skeletonpreparation,N-CWS)对患者生存期的生活质量的改善情况。方法:试验组35例采用N-CWS联合化疗,对照组30例单用化疗。对生活状态评分、疗效、缓解时间、临床受益率、T细胞亚群、NK细胞、副作用进行观察。结果:试验组生活质量评分增加(t=5.653,P<0.05),生活状态评分增加(t=4.212,P<0.05),化疗后缓解时间为(19.63±9.18)d,临床受益率为86%(30/35),NK细胞提高,而有效率、副作用、T细胞亚群变化差异无显著性意义(P>0.05)。结论:口服N-CWS能改善患者的生活质量和体质状态,患者耐受性良好。
AIM:To observe the efficacy of oral nocardia rubra cell wall skeleton preparation(N CWS) for improving patients' quality of life(QOL) in survived period. METHODS:Thirty five cases in the experimental group were treated with oral N CWS and chemotherapy,and 30 cases in the control group only with chemotherapy.Furthermore,the score of QOL,efficacy, remission time, clinical benefit rate,subset of T cells and NK cells and side effect were observed. RESULTS:The score of QOL in the experimental group was increased(t=5.653, P< 0.05),the score of life status was increased(t=4.212,P< 0.05).The clinical benefit rate was 86%(30/35),remission time after chemotherapy was(19.63±9.18) days.NK cells were higher than before. But as efficacy rate, side effect,and subset of T cells were concerned, there were no significant differences between the two groups(P >0.05). CONCLUSION:Oral N CWS can improve physical quality and QOL with good tolerance.
出处
《中国临床康复》
CSCD
2004年第26期5505-5507,共3页
Chinese Journal of Clinical Rehabilitation